| Once-weekly semaglutide in adults with overweight or obesity JPH Wilding, RL Batterham, S Calanna, M Davies, LF Van Gaal, I Lingvay, ... New England Journal of Medicine 384 (11), 989-1002, 2021 | 2013 | 2021 |
| Appetite control K Wynne, S Stanley, B McGowan, S Bloom Journal of Endocrinology 184 (2), 291-318, 2005 | 909 | 2005 |
| Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males WS Dhillo, OB Chaudhri, M Patterson, EL Thompson, KG Murphy, ... The Journal of Clinical Endocrinology & Metabolism 90 (12), 6609-6615, 2005 | 757 | 2005 |
| 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial CW Le Roux, A Astrup, K Fujioka, F Greenway, DCW Lau, L Van Gaal, ... The Lancet 389 (10077), 1399-1409, 2017 | 721 | 2017 |
| Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled … PM O'Neil, AL Birkenfeld, B McGowan, O Mosenzon, SD Pedersen, ... The Lancet 392 (10148), 637-649, 2018 | 621 | 2018 |
| Hormonal regulation of food intake S Stanley, K Wynne, B McGowan, S Bloom Physiological reviews, 2005 | 580 | 2005 |
| Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension JPH Wilding, RL Batterham, M Davies, LF Van Gaal, K Kandler, K Konakli, ... Diabetes, Obesity and Metabolism 24 (8), 1553-1564, 2022 | 264 | 2022 |
| Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation … F Rubino, RV Cohen, G Mingrone, CW le Roux, JI Mechanick, ... The Lancet Diabetes & Endocrinology 8 (7), 640-648, 2020 | 204 | 2020 |
| Central relaxin-3 administration causes hyperphagia in male Wistar rats BMC McGowan, SA Stanley, KL Smith, NE White, MM Connolly, ... Endocrinology 146 (8), 3295-3300, 2005 | 194 | 2005 |
| Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats BM McGowan, SA Stanley, KL Smith, JS Minnion, J Donovan, ... Regulatory peptides 136 (1-3), 72-77, 2006 | 139 | 2006 |
| Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial AD Miras, B Pérez-Pevida, M Aldhwayan, A Kamocka, ER McGlone, ... The lancet Diabetes & endocrinology 7 (7), 549-559, 2019 | 119 | 2019 |
| Low-dose pancreatic polypeptide inhibits food intake in man DR Jesudason, MP Monteiro, BMC McGowan, NM Neary, AJ Park, ... British Journal of Nutrition 97 (3), 426-429, 2007 | 109 | 2007 |
| Peptide YY and appetite control BMC McGowan, SR Bloom Current opinion in pharmacology 4 (6), 583-588, 2004 | 108 | 2004 |
| Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose … DCW Lau, L Erichsen, AM Francisco, A Satylganova, CW le Roux, ... The Lancet 398 (10317), 2160-2172, 2021 | 97 | 2021 |
| Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axis BM McGowan, SA Stanley, J Donovan, EL Thompson, M Patterson, ... American Journal of Physiology-Endocrinology and Metabolism 295 (2), E278-E286, 2008 | 93 | 2008 |
| The prevalence and natural history of pituitary hemorrhage in prolactinoma KN Sarwar, MSB Huda, V Van de Velde, L Hopkins, S Luck, R Preston, ... The Journal of Clinical Endocrinology & Metabolism 98 (6), 2362-2367, 2013 | 82 | 2013 |
| Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A critically appraised topic SK Mahil, SM McSweeney, E Kloczko, B McGowan, JN Barker, CH Smith British Journal of Dermatology 181 (5), 946-953, 2019 | 80 | 2019 |
| The endocrine and metabolic characteristics of a large Bardet-Biedl syndrome clinic population S Mujahid, KF Hunt, YS Cheah, E Forsythe, JM Hazlehurst, K Sparks, ... The Journal of Clinical Endocrinology & Metabolism 103 (5), 1834-1841, 2018 | 76 | 2018 |
| Hypothalamic mapping of orexigenic action and Fos-like immunoreactivity following relaxin-3 administration in male Wistar rats BM McGowan, SA Stanley, NE White, A Spangeus, M Patterson, ... American Journal of Physiology-Endocrinology and Metabolism 292 (3), E913-E919, 2007 | 68 | 2007 |
| The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity J Crane, B McGowan Therapeutic advances in chronic disease 7 (2), 92-107, 2016 | 56 | 2016 |
